At Vitafoods 2008, Chr. Hansen will be show-casing exiting probiotic blends for dietary supplements, including a children-friendly probiotic stick.
Probiotics is a fast growing category within dietary supplements and the emerging awareness of the benefits it can convey to children has lead to an increasing interest worldwide. A healthy flora in the gut does not only improve gut well-being but also beneficially influences the gut interaction with the immune system. Numerous studies in children show good results on both gastrointestinal health and the immune system.
“We engage in working partnerships with companies worldwide on product development of probiotic solutions for children and adults backed by clinical studies. We see a growing interest in probiotics for children’s health and we have very good results with e.g. Acidolac and Trilac on the Polish market and Liveo Kids on the Baltic markets,” says Tine Westerdahl, Head of Marketing, Health & Nutrition Division, Chr. Hansen.
Backed by science
Probiotics have been studied and used for children for several years and are found safe.
“We have used and studied probiotics in children for many years and have documented efficacy in scientific clinical trials and experienced positive effect in clinical use. The effects seen after supplementing the diet with probiotics are best documented within gastrointestinal infection, antibiotic-associated diarrhea, and allergies,” explains Anders Paerrgaard, leading pediatrician, University Clinic of Pediatrics, H:S Hvidovre Hospital, Denmark.
Chr. Hansen focuses strongly on clinical documentation, and a background in science and technology ensures a constant high quality in product development and production.
Chr. Hansen specializes in probiotics for the following areas:
• Children’s Health
• Immune Health
• Gastrointestinal Health
• Women’s Health
Come and meet us at Vitafoods at Stand 226.
On May 6 at 14.00 you can experience a Chr. Hansen presentation on ‘Probiotics and Children’ at the Supplier Theatre.
Chr. Hansen is a global bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. The products include cultures, enzymes, probiotics and natural colors, and all solutions are based on strong research and development competencies coupled with significant technology investments. Revenue in the 2013/14 financial year was EUR 756 million. The company holds a leading market position in all its divisions: Cultures & Enzymes, Health & Nutrition and Natural Colors. It has more than 2,500 dedicated employees in over 30 countries and main production facilities in Denmark, France, USA and Germany. Chr. Hansen was founded in 1874 and is listed on NASDAQ OMX Copenhagen.